Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists

Clinical trial NCT02126579 · COMPLETED

Trial details

NCT number: NCT02126579
Sponsor: Craig L Slingluff, Jr
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Metastatic Melanoma Mucosal Melanoma

Start date: 2014-05-01
Primary completion: 2019-11-20
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.